Myelodysplastic syndromes (MDS) are clonal hematopoietic malignancies that pose a serious health threat. Current therapies include symptomatic treatments for low‐risk and hypomethylating agents for high‐risk MDS. However, many patients develop resistance
Xiaohan Liu +8 more
semanticscholar +1 more source
BMI‐1 modulation and trafficking during M phase in diffuse intrinsic pontine glioma
BMI‐1 (B‐cell‐specific Moloney murine leukemia virus integration site 1) has been implicated in both normal and cancer cell biology. While the canonical function of BMI‐1 involves epigenetic repression, novel extranuclear functions have been recently ...
Banlanjo Umaru +6 more
doaj +1 more source
22P Exploring exportin-1 as a therapeutic vulnerability in lung squamous cell carcinoma
V. Durani +3 more
semanticscholar +1 more source
Melphalan and Exportin 1 Inhibitors Exert Synergistic Antitumor Effects in Preclinical Models of Human Multiple Myeloma. [PDF]
Turner JG +9 more
europepmc +1 more source
A new therapeutic approach to <i>KRAS</i> mutant non-small cell lung cancer: the emerging role of exportin 1 inhibition. [PDF]
von Itzstein MS, Gerber DE.
europepmc +1 more source
Exportin 1 (XPO1; CRM1); histone deacetylase 1 (HDAC1) [PDF]
openaire +1 more source
Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma. [PDF]
DeSisto JA +14 more
europepmc +1 more source
Unbiased screening reveals that blocking exportin 1 overcomes resistance to PI3Kα inhibition in breast cancer. [PDF]
Liu XL +9 more
europepmc +1 more source
Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung Cancer. [PDF]
von Itzstein MS +15 more
europepmc +1 more source
Correction: Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1. [PDF]
Sekihara K +13 more
europepmc +1 more source

